Three-dimensional dosimetry for intralesional radionuclide therapy using mathematical modeling and multimodality imaging

Journal of Nuclear Medicine

Volumn 38, Issue 7, 1997, Pages 1059-1066

  Flux, Glenn D ^a   Webb, Steve ^a   Ott, Robert J ^a   Chittenden, Sarah J ^a   Thomas, Robert ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Dosimetry; Glioma; Image registration; Intralesional therapy; Radioimmunotherapy

Indexed keywords

ARTICLE; DOSIMETRY; GLIOMA; PRIORITY JOURNAL; RADIATION DOSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING;

HUMANS; INJECTIONS, INTRALESIONAL; MODELS, BIOLOGICAL; MODELS, THEORETICAL; RADIOIMMUNOTHERAPY; RADIOISOTOPES; RADIOTHERAPY DOSAGE;

EID: 0030789208     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. 131-labeled anti-tenascin monoclonal antibody 81C6 in patients with glioma and other intracranial malignancies. Cancer Res 1989;49:2807-2813.
2. Loevinger R, Berman M. A revised scheme for calculating the absorbed dose from biologically distributed radionuclides. MIRD pamphlet No. 1, revised. New York, NY: Society of Nuclear Medicine; 1976.
3. 131I-monoclonal antibody (MAb) therapy in patients with recurrent high-grade gliomas: radioactive isotopes in clinical medicine research. In: Radioactive isotopes in clinical medical research. Advances in pharmacological sciences, Basel, Switzerland: Birkhauser Verlag; 1995:29-34.
4. Webb S, Nahum AE. A model for calculating tumor-control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic-cell density. Phys Med Biol 1993;38:653-666.
5. Sgouros G, Barest G, Thekkumthala J, et al. Treatment planning for internal radionuclide therapy: three-dimensional dosimetry for nonuniformly distributed radionuclides. J Nucl Med 1990;31:1884-1891.
6. Sgouros G, Chui S, Pentlow KS, et al. Three-dimensional dosimetry for radioimmunotherapy treatment planning. J Nucl Med 1993;34:1595-1601.
7. Ogawa K, Kanbe N, Uchida I, Yamada Y, Itoh A, Akiyama Y. Accurate three-dimensional dose calculation using a quantitative SPECT image for radioimmunotherapy [Abstract], J Nucl Med 1994;35(suppl):160P.
8. Giap HB, Macey DJ, Bayouth JE, Boyer AE. Validation of a dose-point kernel convolution technique for internal dosimetry. Phys Med Biol 1990;40:365-381.
9. Crank J. The mathematics of diffusion. London: Oxford University Press; 1967.
10. Fielding SL, Flower MA, Ackery D, Kemshead JT, Lashford LS, Lewis I. Dosimetry of iodine-131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study. Eur J Nucl Med 1991;18:308-316.
11. Telenczak P. Apport de la microscopic ionique analytique et des methodes de Monte Carlo (EGS4-Presta) pour l'optimisation des parametres dosimetriques en radiotherapie metabolique [Doctoral thesis No. 846]. Toulouse, France: Universite Paul Sabatier; 1991.
12. Flux GD. Multimodality image registration and its application to the dosimetry of intralesional radionuclide therapy [PhD thesis]. London. England: University of London; 1995.